等待开盘 02-04 09:30:00 美东时间
+3.410
+0.74%
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从9美元升至50美元;韦德布什:维持Ardelyx, Inc."跑赢大市"评级,目标价从16美元升至19美元
01-22 15:09
Citigroup analyst Patrick Cunningham maintains Linde (NASDAQ:LIN) with a Buy and raises the price target from $520 to $540.
01-22 02:56
著名财经节目主持人Jim Cramer称,林德(Linde,LIN)因半导体和工业气体领域势头强劲获看涨评级,其他“俱乐部”股票也获上调评级,因市场正在消化...
2025-12-18 23:32
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30
RBC Capital analyst Arun Viswanathan maintains Linde (NASDAQ:LIN) with a Outperform and lowers the price target from $540 to $490.
2025-12-13 00:29
Linde PLC's (NYSE:LIN) short interest as a percent of float has risen 5.26% sin...
2025-12-10 01:00
今日重点评级关注:Guggenheim:维持Cybin Inc. Common Shares"买入"评级,目标价从39美元升至48美元;HC Wainwright & Co.:维持Capricor Therapeutics"买入"评级,目标价从24美元升至60美元
2025-12-04 09:38
Linde ( ($LIN) ) just unveiled an update. On December 3, 2025, Linde plc entere...
2025-12-04 05:35
CICC analyst Shanshan Shen initiates coverage on Linde (NASDAQ:LIN) with a Outperform rating and announces Price Target of $510.
2025-12-03 20:43
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
2025-11-12 11:43